Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,683,914
+$96,018 QoQ
Shares Held
3,390
-4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#712
of 1,732 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2022CallValue
$5,000
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. VRTX ranks #1 (40.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,390 | $1,683,914 | |
| 2 | MRNA |
Moderna, Inc.
|
14,616 | $1,023,558 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,330 | $570,314 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
645 | $402,183 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,732 | $367,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
19,550 | $71,748 | |
| 7 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 8 | NGEN |
Nervgen Pharma Corp.
|
17,036 | $35,094 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,683,914 | 3,390 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,587,896 | 3,556 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,577,239 | 3,479 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,401,679 | 3,579 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,840,456 | 4,134 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,665,055 | 5,497 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,450,928 | 3,603 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,664,056 | 3,578 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,752,544 | 3,739 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,646,959 | 3,940 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,584,022 | 3,893 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,500,498 | 4,315 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,585,002 | 4,504 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,289,266 | 4,092 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,237,711 | 4,286 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,183,639 | 4,088 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,145,476 | 4,065 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,000 | 100 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $1,013,346 | 3,883 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $698,767 | 3,182 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $439 | 2 | Call | Sole | 2022-02-14 | |
| 2020-12-31 | $388,070 | 1,642 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $491,448 | 1,806 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $587,877 | 2,025 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $470,665 | 1,978 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||